Skip to main content

Ultraprocessed Food Increases Risk for Death With Type 2 Diabetes

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

WEDNESDAY, Aug. 2, 2023 -- Higher consumption of ultraprocessed food (UPF) is associated with lower survival and higher cardiovascular mortality in patients with type 2 diabetes, according to a study published online July 26 in the American Journal of Clinical Nutrition.

Marialaura Bonaccio, Ph.D., from the IRCCS Istituto Neurologico Mediterraneo Neuromed in Pozzilli, Italy, and colleagues evaluated the association of UPF intake with all-cause and cardiovascular disease (CVD) mortality among 1,065 participants with type 2 diabetes followed for a median of 11.6 years.

The researchers found that greater UPF intake (quartile 4: ≥10.5 percent of total food eaten for women and ≥9 percent for men) versus the lowest (quartile 1: UPF <4.7 and <3.7 percent for women and men, respectively), was associated with a higher risk for both all-cause (hazard ratio, 1.70) and CVD mortality (hazard ratio, 2.64). Associations were not substantially changed with inclusion of the Mediterranean diet score in the model (hazard ratios, 1.64 and 2.55 for all-cause and CVD mortality, respectively). There was a linear dose-response relationship observed between UPF intake with both all-cause and CVD mortality.

"Besides prioritizing the adoption of a diet based on nutritional requirements, dietary guidelines for the management of type 2 diabetes should also recommend limiting UPF," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted August 2023

Read this next

American Diabetes Association, June 21-24

The annual meeting of the American Diabetes Association was held this year from June 21 to 24 in Orlando, Florida, drawing more than 15,000 participants from around the world...

Few With Type 2 Diabetes Receive Guideline-Recommended CKD Screening

MONDAY, July 1, 2024 -- Fewer than one-quarter of patients with type 2 diabetes (T2D) receive recommended chronic kidney disease (CKD) screening, according to a study published...

ADA: Bisphenol A Linked to Reduced Peripheral Insulin Sensitivity

THURSDAY, June 27, 2024 -- Bisphenol A (BPA) administration is associated with reduced peripheral insulin sensitivity among healthy adults, according to a study presented at the...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.